CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO)
发明人:
申请号：
IL21515811
公开号：
IL215158A
申请日:
2011.09.15
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
There is provided compounds of formula (I): wherein R1, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. PI3-K, particularly class I PI3K) is desired and/or required, and particularly in the treatment of cancer.
